Kevin Pacheco-Barrios

Dr. Kevin Pacheco-Barrios

Neuromodulation Center and Center for Clinical Research Learning, Spaulding Rehabilitation Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2022 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
ANAlba Navarro-Flores
Alba Navarro-Flores
JFJose Ernesto Fernandez-Chinguel
Jose Ernesto Fernandez-Chinguel
NPNiels Pacheco-Barrios
Niels Pacheco-Barrios
DSDavid R. Soriano-Moreno
David R. Soriano-Moreno
KPKevin Pacheco-Barrios
Kevin Pacheco-Barrios

15 September 2020 in Expert Review of Medical Devices
Verified
Journal Article
Closed access
KPKevin Pacheco-Barrios
Kevin Pacheco-Barrios
ACAlejandra Cardenas
Alejandra Cardenas
ATAurore Thibaut
Aurore Thibaut
BCBeatriz Costa
Beatriz Costa
IFIsadora Ferreira
Isadora Ferreira
Felipe FregniFelipe Fregni
Felipe Fregni
Transcranial Direct Current Stimulation (tDCS) is a non-invasive neuromodulation technique which has been widely studied for the treatment of chronic pain. It is considered a promising and safe alt...

24 January 2019 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
JZJessica Hanae Zafra-Tanaka
Jessica Hanae Zafra-Tanaka
KPKevin Pacheco-Barrios
Kevin Pacheco-Barrios
WTWalter Andree Tellez
Walter Andree Tellez
ATAlvaro Taype-Rondan
Alvaro Taype-Rondan
Dog-assisted therapy (DAT) is a non-pharmacological intervention based on the interaction between patients and dogs, which has been proposed to help adults with dementia. However, evidence to support it is lacking. Thus, we aim to evaluate the effects of DAT on this population and to assess the certainty of the evidence of the RCTs estimates. A systematic search was performed. We included randomized controlled trials (RCTs) and quasi-experimental (QE) controlled studies published up to March 2018, which evaluated the beneficial and deleterious effects of DAT in adults with dementia. Mean differences (MD) or standardized mean differences (SMD) and their 95% confidence intervals (95% CI) were calculated and random effects meta-analyses were performed. Certainty of evidence was assessed for RCTs estimates using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology. The study protocol has been registered in PROSPERO (CRD42018090434). Ten studies (six RCTs and four QE controlled studies) were eligible for inclusion. Meta-analysis of RCTs showed no effect of DAT in daily life activities (SMD: 0.16; 95% CI: -0.80 to 1.12), depression (SMD: -0.45; 95% CI: -2.81 to 1.91), agitation (SDM: -1.12; 95% CI: -2.67 to 0.43), quality of life (SDM: 0.16; 95% CI: -0.41 to 0.73), and cognitive impairment (SDM: -0.52; 95% CI: -1.33 to 0.30), but it found a beneficial effect in apathy (1 study, n = 37, MD: 1.81; 95% CI: 1.26 to 2.36). All outcomes had a very low certainty of evidence according to GRADE methodology. RCTs evidence of very low certainty suggests that, in adults with dementia, DAT has no effect in daily life activities, depression, agitation, quality of life, and cognitive impairment, although one small study found an apparent beneficial effect in apathy. More well-designed and correctly reported studies are needed in order to provide a conclusion. CRD42018090434 (PROSPERO).

1 November 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
KPKevin Pacheco-Barrios
Kevin Pacheco-Barrios
SGStefano Giannoni-Luza
Stefano Giannoni-Luza
ANAlba Navarro-Flores
Alba Navarro-Flores
IRIngrid Rebello‐Sanchez
Ingrid Rebello‐Sanchez
JPJoao Parente
Joao Parente
Felipe FregniFelipe Fregni
Felipe Fregni
Background: Stroke burden characterization studies in low‐ and middle‐income countries are scarce. We estimated the burden of stroke and its risk factors in Latin America and the Caribbean (LAC). Methods and Results: We extracted GBD (Global Burden of Disease) study 2019 data on overall stroke and 3 subtypes (ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage) for 20 LAC countries. We estimated absolute and age‐standardized rates of disability‐adjusted life years, years of life lost, years lived with disability, and deaths. The population‐attributable fractions of 17 risk factors were estimated. All analyses were performed at regional and national levels by stroke subtype, sex, and age subgroups. In 2019, the LAC region had the fourth largest stroke burden worldwide (6.8 million disability‐adjusted life years), predominantly attributable to premature deaths (89.5% of disability‐adjusted life years). Intracerebral hemorrhage was the primary cause of the overall stroke burden (42% of disability‐adjusted life years), but ischemic stroke was the leading cause of disability (69% of total years lived with disability). Haiti and Honduras had the highest age‐standardized rates. Older adults and men had the largest burdens, although women had the highest rate of disability. Socioeconomic development level did not influence the burden. The major risk factor clusters were metabolic (high systolic blood pressure [population‐attributable fraction=53%] and high body mass index [population‐attributable fraction=37%]), which were more influential in hemorrhagic events, women, and older adults. Household air pollution was an important risk factor in low‐income countries in LAC. Conclusions: The stroke burden and stroke‐related mortality in LAC are higher than the worldwide averages. However, stroke is a highly preventable disease in this region. Up to 90% of the burden could be reduced by targeting 2 modifiable factors: blood pressure and body mass index. Further research and implementation of primary and secondary prevention interventions are needed, as well as integrated national stroke care programs for acute, subacute, and rehabilitation management in LAC.

2 March 2021 in Epilepsia
Verified
Journal Article
Closed access
PDF file
CACarlos Alva-Diaz
Carlos Alva-Diaz
ANAlba Navarro-Flores
Alba Navarro-Flores
OROscar Rivera‐Torrejon
Oscar Rivera‐Torrejon
AHAndrely Huerta‐Rosario
Andrely Huerta‐Rosario
RMRoberto A. Molina
Roberto A. Molina
KPKevin Pacheco-Barrios
Kevin Pacheco-Barrios

8 April 2020 in Pain Practice
Verified
Journal Article
Closed access
PDF file
MMMarionna Münger
Marionna Münger
CPCamila B. Pinto
Camila B. Pinto
KPKevin Pacheco-Barrios
Kevin Pacheco-Barrios
DDDante Duarte
Dante Duarte
MGMuhamed Enes Gunduz
Muhamed Enes Gunduz
Felipe FregniFelipe Fregni
Felipe Fregni